TY - JOUR
T1 - Exploring approaches for predictive cancer patient digital twins
T2 - Opportunities for collaboration and innovation
AU - Stahlberg, Eric A.
AU - Abdel-Rahman, Mohamed
AU - Aguilar, Boris
AU - Asadpoure, Alireza
AU - Beckman, Robert A.
AU - Borkon, Lynn L.
AU - Bryan, Jeffrey N.
AU - Cebulla, Colleen M.
AU - Chang, Young Hwan
AU - Chatterjee, Ansu
AU - Deng, Jun
AU - Dolatshahi, Sepideh
AU - Gevaert, Olivier
AU - Greenspan, Emily J.
AU - Hao, Wenrui
AU - Hernandez-Boussard, Tina
AU - Jackson, Pamela R.
AU - Kuijjer, Marieke
AU - Lee, Adrian
AU - Macklin, Paul
AU - Madhavan, Subha
AU - McCoy, Matthew D.
AU - Mohammad Mirzaei, Navid
AU - Razzaghi, Talayeh
AU - Rocha, Heber L.
AU - Shahriyari, Leili
AU - Shmulevich, Ilya
AU - Stover, Daniel G.
AU - Sun, Yi
AU - Syeda-Mahmood, Tanveer
AU - Wang, Jinhua
AU - Wang, Qi
AU - Zervantonakis, Ioannis
N1 - Funding Information:
This work has been supported in part by the Joint Design of Advanced Computing Solutions for Cancer (JDACS4C) program established by the US Department of Energy (DOE) and the National Cancer Institute (NCI) of the National Institutes of Health NIH), Leidos Biomedical Research contract no. 75N91019D00024. RB's work was supported by the Department of Defense Breakthrough Award (BC161497), which is aimed at applying models to a preclinical model of breast cancer. This material is based upon work supported by the U.S. Department of Energy, Office of Science, Office of Advanced Scientific Computing Research under Award Numbers DE-SC0021655, DE-SC0021630, and DE-SC0021631. Acknowledgments
Publisher Copyright:
2022 Stahlberg, Abdel-Rahman, Aguilar, Asadpoure, Beckman, Borkon, Bryan, Cebulla, Chang, Chatterjee, Deng, Dolatshahi, Gevaert, Greenspan, Hao, Hernandez-Boussard, Jackson, Kuijjer, Lee, Macklin, Madhavan, McCoy, Mohammed Mirzaei, Razzaghi, Rocha, Shahriyari, Shmulevich, Stover, Sun, Syeda-Mahmood, Wang, Wang and Zervantonakis.
PY - 2022/10/6
Y1 - 2022/10/6
N2 - We are rapidly approaching a future in which cancer patient digital twins will reach their potential to predict cancer prevention, diagnosis, and treatment in individual patients. This will be realized based on advances in high performance computing, computational modeling, and an expanding repertoire of observational data across multiple scales and modalities. In 2020, the US National Cancer Institute, and the US Department of Energy, through a trans-disciplinary research community at the intersection of advanced computing and cancer research, initiated team science collaborative projects to explore the development and implementation of predictive Cancer Patient Digital Twins. Several diverse pilot projects were launched to provide key insights into important features of this emerging landscape and to determine the requirements for the development and adoption of cancer patient digital twins. Projects included exploring approaches to using a large cohort of digital twins to perform deep phenotyping and plan treatments at the individual level, prototyping self-learning digital twin platforms, using adaptive digital twin approaches to monitor treatment response and resistance, developing methods to integrate and fuse data and observations across multiple scales, and personalizing treatment based on cancer type. Collectively these efforts have yielded increased insights into the opportunities and challenges facing cancer patient digital twin approaches and helped define a path forward. Given the rapidly growing interest in patient digital twins, this manuscript provides a valuable early progress report of several CPDT pilot projects commenced in common, their overall aims, early progress, lessons learned and future directions that will increasingly involve the broader research community.
AB - We are rapidly approaching a future in which cancer patient digital twins will reach their potential to predict cancer prevention, diagnosis, and treatment in individual patients. This will be realized based on advances in high performance computing, computational modeling, and an expanding repertoire of observational data across multiple scales and modalities. In 2020, the US National Cancer Institute, and the US Department of Energy, through a trans-disciplinary research community at the intersection of advanced computing and cancer research, initiated team science collaborative projects to explore the development and implementation of predictive Cancer Patient Digital Twins. Several diverse pilot projects were launched to provide key insights into important features of this emerging landscape and to determine the requirements for the development and adoption of cancer patient digital twins. Projects included exploring approaches to using a large cohort of digital twins to perform deep phenotyping and plan treatments at the individual level, prototyping self-learning digital twin platforms, using adaptive digital twin approaches to monitor treatment response and resistance, developing methods to integrate and fuse data and observations across multiple scales, and personalizing treatment based on cancer type. Collectively these efforts have yielded increased insights into the opportunities and challenges facing cancer patient digital twin approaches and helped define a path forward. Given the rapidly growing interest in patient digital twins, this manuscript provides a valuable early progress report of several CPDT pilot projects commenced in common, their overall aims, early progress, lessons learned and future directions that will increasingly involve the broader research community.
KW - artificial intelligence
KW - cancer patient
KW - digital twins
KW - machine learning
KW - mathematical modeling
KW - oncology
KW - predictive medicine
UR - http://www.scopus.com/inward/record.url?scp=85140287308&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140287308&partnerID=8YFLogxK
U2 - 10.3389/fdgth.2022.1007784
DO - 10.3389/fdgth.2022.1007784
M3 - Article
AN - SCOPUS:85140287308
SN - 2673-253X
VL - 4
JO - Frontiers in Digital Health
JF - Frontiers in Digital Health
M1 - 1007784
ER -